JFNAX
Price
$63.09
Change
-$0.44 (-0.69%)
Updated
May 8 closing price
Net Assets
4.66B
VGHCX
Price
$169.94
Change
-$2.78 (-1.61%)
Updated
May 8 closing price
Net Assets
38.2B
Ad is loading...

JFNAX vs VGHCX

Header iconJFNAX vs VGHCX Comparison
Open Charts JFNAX vs VGHCXBanner chart's image
Janus Henderson Global Life Sciences A
Price$63.09
Change-$0.44 (-0.69%)
VolumeN/A
Net Assets4.66B
Vanguard Health Care I
Price$169.94
Change-$2.78 (-1.61%)
VolumeN/A
Net Assets38.2B
JFNAX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNAX vs. VGHCX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNAX is a Buy and VGHCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 38.2B vs. JFNAX (4.66B). VGHCX pays higher dividends than JFNAX: VGHCX (0.86) vs JFNAX (0.13). JFNAX was incepted earlier than VGHCX: JFNAX (16 years) vs VGHCX (41 years). JFNAX (0.98) is less costly to investors than VGHCX (0.35). JFNAX is a more actively managed with annual turnover of: 35.00 vs. VGHCX (29.00). JFNAX has a lower initial minimum investment than VGHCX: JFNAX (2500) vs VGHCX (3000). JFNAX annual gain was more profitable for investors over the last year : -11.41 vs. VGHCX (-18.14). JFNAX return over 5 years is better than : 9.96 vs. VGHCX (-14.23).
JFNAXVGHCXJFNAX / VGHCX
Total Expense Ratio0.980.35280%
Annual Report Gross Expense Ratio0.980.35280%
Fund Existence16 years41 years-
Gain YTD-4.106-5.49475%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B38.2B12%
Annual Yield % from dividends0.130.8615%
Returns for 1 year-11.41-18.1463%
Returns for 3 years9.19-12.67-73%
Returns for 5 years9.96-14.23-70%
Returns for 10 years9.08-24.25-37%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQSCX22.78N/A
N/A
Virtus KAR Small-Cap Value C
SGTTX67.39N/A
N/A
Columbia Seligman Global Tech Inst2
AKRSX70.64N/A
N/A
Akre Focus Supra Institutional
LOGSX20.26N/A
N/A
Live Oak Health Sciences
SEECX32.85N/A
N/A
Steward Values Enhanced Lg Cap I